NCT07587151Completed
Remote Pharmacy Services Plus Continuous Glucose Monitoring in an Underserved Population
The Role of Remote Pharmacy Services With Continuous Glucose Monitoring in an Underserved Population
Source: ClinicalTrials.gov · Last updated 14 May 2026
Brief summary (registry, in English)
The purpose of this study is to improve T2DM (type 2 diabetes mellitus) management and health outcomes among underserved patients who receive primary care at a federally qualified health center (FQHC) in Winnebago County, Illinois. Our aim is to assess the feasibility and preliminary effectiveness of a pilot program combining continuous glucose monitoring (CGM) with monthly telehealth appointments to improve diabetes management in FQHC patients who have uncontrolled T2DM (HbA1c \>7%). Researchers will compare those who receive the intervention (usual in-person care + CGM + 2 telehealth visits with a clinical pharmacist and family medicine resident) with those receiving a CGM in additional to usual care (in-person care + CGM). Participants will have their HbA1c tested and complete surveys to assess diabetes-related distress and diabetes management self-efficacy at baseline and 3 and 6 months from baseline. This will allow the investigators to raise glucose awareness for all participants utilizing CGM technology while simultaneously determining the necessity of more frequent follow-up than the guideline recommended intervals of 3 months for uncontrolled diabetes in an under-resourced population. This will also allow us to evaluate the feasibility of telehealth in delivering more frequent follow-up care to patients with T2DM.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 46 (actual)
- First submitted
- 8 May 2026
- Start date
- 31 Mar 2025
- Primary completion date
- 5 Dec 2025
- Lead sponsor
- University of Illinois Chicago
- Diseases
- Type 2 diabetes
- NCT number
- NCT07587151
What you commit to
- Study type: Interventional
- Participants enrolled: 46
- From 31 Mar 2025 to the primary completion date, 5 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with gestational diabetes mellitus or Type 1 diabetes mellitus
Lab values
- Current Continuous Glucose Monitoring device (CGM) users
Age
- Patients younger than 18 years of age
Other
- Patients in correctional facilities
- Pregnant or lactating women
Who the study is looking for
- Patient receiving primary care from the study clinical site
- Uncontrolled T2DM (HbA1c \>7%)
- 18 years of age and older
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Illinois College of Medicine Rockford Coordinator of this site? Confirm its status | Rockford | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.